ATE228374T1 - Arzneiverabreichungssystem - Google Patents

Arzneiverabreichungssystem

Info

Publication number
ATE228374T1
ATE228374T1 AT94918945T AT94918945T ATE228374T1 AT E228374 T1 ATE228374 T1 AT E228374T1 AT 94918945 T AT94918945 T AT 94918945T AT 94918945 T AT94918945 T AT 94918945T AT E228374 T1 ATE228374 T1 AT E228374T1
Authority
AT
Austria
Prior art keywords
matrix
drug
drug administration
administration system
receptor
Prior art date
Application number
AT94918945T
Other languages
English (en)
Inventor
Margaret Joan Taylor
Original Assignee
Univ Montfort
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montfort filed Critical Univ Montfort
Application granted granted Critical
Publication of ATE228374T1 publication Critical patent/ATE228374T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94918945T 1993-06-30 1994-06-27 Arzneiverabreichungssystem ATE228374T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313484A GB9313484D0 (en) 1993-06-30 1993-06-30 Drug system ii
PCT/GB1994/001384 WO1995001186A1 (en) 1993-06-30 1994-06-27 Drug system

Publications (1)

Publication Number Publication Date
ATE228374T1 true ATE228374T1 (de) 2002-12-15

Family

ID=10738039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918945T ATE228374T1 (de) 1993-06-30 1994-06-27 Arzneiverabreichungssystem

Country Status (11)

Country Link
US (2) US5902607A (de)
EP (1) EP0706401B1 (de)
JP (1) JP4572008B2 (de)
AT (1) ATE228374T1 (de)
AU (1) AU7004194A (de)
DE (1) DE69431800T2 (de)
DK (1) DK0706401T3 (de)
ES (1) ES2185654T3 (de)
GB (1) GB9313484D0 (de)
PT (1) PT706401E (de)
WO (1) WO1995001186A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system
GB0116860D0 (en) * 2001-07-10 2001-09-05 Univ Montfort Gel compositions
AU2003301064A1 (en) 2002-12-17 2004-07-14 Massachusetts Institute Of Technology Stimuli-responsive systems for controlled drug delivery
GB0412631D0 (en) * 2004-06-07 2004-07-07 Cambridge Applied Polymers Ltd Polymer release system
CN101184780B (zh) 2005-05-05 2012-10-03 森馨香料公司 β-葡聚糖和甘露聚糖的制备
WO2007047922A2 (en) 2005-10-19 2007-04-26 Smartcells, Inc. Polymer-drug conjugates
WO2008079897A2 (en) * 2006-12-22 2008-07-03 The Regents Of The University Of California Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
BRPI1007457A2 (pt) 2009-01-28 2015-08-25 Smartcells Inc Conjungado, formulação de liberação prolongada, e, sistema de distribuição de bomba.
CA2750223A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Exogenously triggered controlled release materials and uses thereof
AU2010208295A1 (en) * 2009-01-28 2011-08-04 Smartcells, Inc. Polynucleotide aptamer-based cross -linked materials and uses thereof
JP2012516342A (ja) 2009-01-28 2012-07-19 スマートセルズ・インコーポレイテツド 結晶性インスリン複合体
WO2010088286A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Synthetic conjugates and uses thereof
CA2754950A1 (en) * 2009-03-20 2010-09-23 Smartcells, Inc. Terminally-functionalized conjugates and uses thereof
EP2408470A4 (de) 2009-03-20 2012-08-29 Smartcells Inc Lösliche nichtdepot-insulinkonjugate und ihre verwendung
US9095623B2 (en) * 2009-03-20 2015-08-04 Smartcells, Inc. Terminally-functionalized conjugates and uses thereof
US9074015B2 (en) 2010-07-28 2015-07-07 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
EP2598170A4 (de) 2010-07-28 2016-07-06 Smartcells Inc Arzneimittel-liganden-konjugate, deren synthese und zwischenprodukte daraus
US9068013B2 (en) 2010-07-28 2015-06-30 Smart Cells, Inc. Recombinant lectins, binding-site modified lectins and uses thereof
CA2902256A1 (en) * 2012-02-17 2013-08-22 Massachusetts Institute Of Technology Self-regulated peptide hydrogel for insulin delivery
GB201310185D0 (en) 2013-06-07 2013-07-24 Univ Montfort Container
GB201314640D0 (en) 2013-08-15 2013-10-02 Univ Montfort Matrix gel
AU2014329567B2 (en) 2013-10-04 2019-07-25 Merck Sharp & Dohme Corp. Glucose-responsive insulin conjugates
EP3600381A4 (de) 2017-03-23 2021-06-16 Merck Sharp & Dohme Corp. Glucosereaktives insulin mit einem dreiwertigen zuckercluster zur behandlung von diabetes
WO2019125879A2 (en) 2017-12-18 2019-06-27 Merck Sharp & Dohme Corp. Conjugate based systems for controlled insulin delivery
EP3727424A4 (de) 2017-12-18 2021-10-27 Merck Sharp & Dohme Corp. Konjugatbasierte systeme für kontrollierte insulinfreisetzung
CN108721605B (zh) * 2018-06-01 2022-10-14 华南师范大学 一种装载有胰岛素的纳米粒子及其应用
JP2023510089A (ja) * 2019-12-13 2023-03-13 フォリウムラボ インコーポレーティッド 炭水化物ポリマー及び活性成分を備える錯体及びそれらを調製する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348387A (en) * 1979-07-31 1982-09-07 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
ZA922425B (en) * 1991-04-02 1993-02-24 Biotech Australia Pty Ltd Oral delivery systems for microparticles
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system

Also Published As

Publication number Publication date
DK0706401T3 (da) 2003-03-03
GB9313484D0 (en) 1993-08-11
AU7004194A (en) 1995-01-24
JPH09501416A (ja) 1997-02-10
JP4572008B2 (ja) 2010-10-27
DE69431800D1 (de) 2003-01-09
PT706401E (pt) 2003-03-31
DE69431800T2 (de) 2003-09-04
EP0706401B1 (de) 2002-11-27
WO1995001186A1 (en) 1995-01-12
US5902607A (en) 1999-05-11
EP0706401A1 (de) 1996-04-17
ES2185654T3 (es) 2003-05-01
US6410053B1 (en) 2002-06-25

Similar Documents

Publication Publication Date Title
DE69431800D1 (de) Arzneiverabreichungssystem
US5656284A (en) Oral transmucosal delivery tablet and method of making it
CS9004859A2 (en) Method of adhesive plaster production that contains oestrogen as active substance
WO2003077972A8 (en) Implantable drug delivery system
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
BR9608542A (pt) Composição para a liberação sustentada de hormónio do crescimento humano
DE69508938D1 (de) Transdermales arzneistoff-abgabesystem
ATE516049T1 (de) Formulierung zur gesteuerten arzneistofffreisetzung durch kombination hydrophiler und hydrophober stoffe
ATE59302T1 (de) Klebende schicht zur transdermalen freigabe.
KR900017575A (ko) 경피 약물전달 기기 및 방법
KR910009264A (ko) 2-아미노-6-n-프로필아미노-4,5,6,7-테트라하이드로벤조티아졸의 경피 투여
ZA946698B (en) Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
UA35569C2 (uk) Композиція для пролонгованого і контрольованого вивільнення пептидної лікарської речовини і спосіб її одержання, спосіб приготування суспензії, що призначена для парентерального введення
ES2135458T3 (es) Sistema de medicamento que comprende una matriz de gel que contiene un farmaco inmobilizado.
EP0301856A3 (en) Delivery system
IT1243745B (it) Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
NO993385L (no) Transdermalt terapeutisk system for avgivelse av hormoner
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
EP0873751A3 (de) Pharmazeutisches produkt zur anwendung auf der mukosa der gebärmutter
PL326499A1 (en) Transcutateous therapeutic system (tts) for administration of active substances used in treating narcotic dependence or drug addiction
Tkachenko The choice of a method for postoperative analgesia using fentanyl
CA1269326C (en) ADHESIVE LAYER FOR TRANDERMAL ADMINISTRATION OF DRUGS
MY114610A (en) Controlled drug delivery system for diltiazem.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0706401

Country of ref document: EP